Panacea Biotec rises 6% on EIR from USFDA for Baddi plant - Moneycontrol.com

Moneycontrol.com
Panacea Biotec rises 6% on EIR from USFDA for Baddi plant
Moneycontrol.com
Shares of Panacea Biotec rose 6 percent intraday Friday as it received establishment inspection report (EIR) from USFDA for its Baddi plant. The company announced the receipt of EIR from the US Food & Drug Administration (USFDA) indicating the formal ...
Panacea Biotec gets USFDA nod for Baddi plantIndiainfoline
Panacea Biotec gets EIR from USFDA for its Baddi facilityETHealthworld.comall 6 news